Cas:59160-29-1 N-(2,6-Dimethylphenylcarbamoylmethyl)iminodiacetic Acid manufacturer & supplier

We serve Chemical Name:N-(2,6-Dimethylphenylcarbamoylmethyl)iminodiacetic Acid CAS:59160-29-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-(2,6-Dimethylphenylcarbamoylmethyl)iminodiacetic Acid

Chemical Name:N-(2,6-Dimethylphenylcarbamoylmethyl)iminodiacetic Acid
CAS.NO:59160-29-1
Synonyms:2-[carboxymethyl-[2-(2,6-dimethylanilino)-2-oxoethyl]amino]acetic acid;EINECS 261-636-4;MFCD00038399
Molecular Formula:C14H18N2O5
Molecular Weight:294.30300
HS Code:2924299090

Physical and Chemical Properties:
Melting point:210ºC (dec.)(lit.)
Boiling point:546.3ºC at 760 mmHg
Density:1.352 g/cm3
Index of Refraction:1.5110 (estimate)
PSA:106.94000
Exact Mass:294.12200
LogP:0.78610

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-[carboxymethyl-[2-(2,6-dimethylanilino)-2-oxoethyl]amino]acetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00038399 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 261-636-4 Use and application,2-[carboxymethyl-[2-(2,6-dimethylanilino)-2-oxoethyl]amino]acetic acid technical grade,usp/ep/jp grade.


Related News: The Environmental Working Group, a nonprofit advocacy organization, applauded the bill’s introduction. N-(2,6-Dimethylphenylcarbamoylmethyl)iminodiacetic Acid manufacturer APIs are generally manufactured through a variety of processes that include. N-(2,6-Dimethylphenylcarbamoylmethyl)iminodiacetic Acid supplier The company reported that it was cooperating with the Justice Department probe and that an outside law firm was also “investigating these allegations thoroughly.” N-(2,6-Dimethylphenylcarbamoylmethyl)iminodiacetic Acid vendor International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. N-(2,6-Dimethylphenylcarbamoylmethyl)iminodiacetic Acid factory Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.